chr12-53328143-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001173467.3(SP7):c.*3C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000392 in 1,605,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
SP7
NM_001173467.3 3_prime_UTR
NM_001173467.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.354
Genes affected
SP7 (HGNC:17321): (Sp7 transcription factor) This gene encodes a member of the Sp subfamily of Sp/XKLF transcription factors. Sp family proteins are sequence-specific DNA-binding proteins characterized by an amino-terminal trans-activation domain and three carboxy-terminal zinc finger motifs. This protein is a bone specific transcription factor and is required for osteoblast differentiation and bone formation.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SP7 | NM_001173467.3 | c.*3C>T | 3_prime_UTR_variant | 3/3 | ENST00000536324.4 | NP_001166938.1 | ||
SP7 | NM_001300837.2 | c.*3C>T | 3_prime_UTR_variant | 3/3 | NP_001287766.1 | |||
SP7 | NM_152860.2 | c.*3C>T | 3_prime_UTR_variant | 2/2 | NP_690599.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SP7 | ENST00000536324.4 | c.*3C>T | 3_prime_UTR_variant | 3/3 | 2 | NM_001173467.3 | ENSP00000443827 | P1 | ||
SP7 | ENST00000303846.3 | c.*3C>T | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000302812 | P1 | |||
SP7 | ENST00000537210.2 | downstream_gene_variant | 1 | ENSP00000441367 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000984 AC: 23AN: 233834Hom.: 0 AF XY: 0.000141 AC XY: 18AN XY: 128084
GnomAD3 exomes
AF:
AC:
23
AN:
233834
Hom.:
AF XY:
AC XY:
18
AN XY:
128084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000392 AC: 57AN: 1453824Hom.: 0 Cov.: 29 AF XY: 0.0000595 AC XY: 43AN XY: 722824
GnomAD4 exome
AF:
AC:
57
AN:
1453824
Hom.:
Cov.:
29
AF XY:
AC XY:
43
AN XY:
722824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74312
GnomAD4 genome
AF:
AC:
6
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 18, 2024 | Variant summary: SP7 c.*3C>T is located in the untranslated mRNA region downstream of the termination codon. The variant allele was found at a frequency of 9.8e-05 in 233834 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SP7 causing Osteogenesis Imperfecta Type 12, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.*3C>T in individuals affected with Osteogenesis Imperfecta Type 12 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at